News

Transplantation improves survival after cladribine-based therapy for patients with relapsed/refractory acute myeloid leukemia ...
A Texas mom shared heartwarming video of her daughter’s delight after her brother came to visit her in the hospital. Abby was ...
Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial – – Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall ...
The new test focuses on mutations in the NPM1 and FLT3 genes, which are among the most common causes of leukemia in younger ...
Breeze Hunter, a 22-year-old college student, struggled for months with a sinus infection she couldn’t shake. She was later ...
U-32 HIGH SCHOOL HOSTED ITS YEARLY BLOOD DRIVE WITH 65 PEOPLE SIGNING ABOUT TO DONATE.... THE AMERICAN RED CROSS SAYS IN VERMONT ALONE ROUGHLY 80 UNITS OF BLOOD ARE NEEDE ...
A revolutionary bone marrow test helped save a woman’s life by detecting her leukemia relapse months before standard methods.
TScan Therapeutics, Inc.’s TCRX share price has surged by 5.15%, which has investors questioning if this is right time to ...
The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...